Author: admin

Cutaneous Lupus Erythematosus Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

DelveInsight’s, “Cutaneous Lupus Erythematosus Pipeline Insight 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Cutaneous Lupus Erythematosus pipeline landscape. It covers the Cutaneous Lupus Erythematosus Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cutaneous Lupus Erythematosus Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Explore the comprehensive insights by DelveInsight and stay ahead in understanding the Cutaneous Lupus Erythematosus Treatment Landscape. Click here to read more @ Cutaneous Lupus Erythematosus Pipeline Outlook

Key Takeaways from the Cutaneous Lupus Erythematosus Pipeline Report

  • In April 2025, AstraZeneca announced a study are to evaluate the efficacy of anifrolumab compared with placebo in reducing skin disease in participants with active chronic and/or subacute CLE who are refractory and/or intolerant to antimalarial therapy. The secondary objectives of the study are to evaluate additional efficacy parameters of anifrolumab, safety, tolerability, quality of life, pharmacokinetics, pharmacodynamics, and immunogenicity.
  • In April 2025, Biogen conducted a study is to learn about the effect litifilimab has on lowering the activity of the skin disease. Researchers will measure symptoms of CLE over time using a variety of scoring tools. These include the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI), the Cutaneous Lupus Activity of Investigator’s Global Assessment-Revised (CLA-IGA-R), and the SELENA-SLEDAI Flare Index (SFI).
  • In April 2025, Pfizer organized a study is to learn about the effects, safety and how PF-06823859 is processed in adults with cutaneous lupus erythematosus (CLE) or systemic lupus erythematosus (SLE) showing some skin symptoms.
  • DelveInsight’s Cutaneous Lupus Erythematosus pipeline report depicts a robust space with 10+ active players working to develop 12+ pipeline therapies for Cutaneous Lupus Erythematosus treatment.
  • The leading Cutaneous Lupus Erythematosus Companies such as Hoth Therapeutics, Zylo Therapeutics, Sanofi, Gilead Sciences, Bristol-Myers Squibb, Merck KGaA, Kyowa Kirin Co., Ltd., Priothera Ltd., Centessa Pharmaceuticals, and Horizon Therapeutics and others.
  • Promising Cutaneous Lupus Erythematosus Pipeline Therapies such as Litifilimab, Daxdilimab, SOTYKTU (deucravacitinib), Edecesertib, DS-7011a, Enpatoran, and others.

Discover groundbreaking developments in Cutaneous Lupus Erythematosus therapies! Gain in-depth knowledge of key Cutaneous Lupus Erythematosus clinical trials, emerging drugs, and market opportunities @ Cutaneous Lupus Erythematosus Clinical Trials Assessment

Cutaneous Lupus Erythematosus Emerging Drugs Profile

  • BIIB059: Biogen

Litifilimab (known as BIIB059), discovered and developed in-house by Biogen scientists, is a humanized IgG1 monoclonal antibody (mAb) targeting blood dendritic cell antigen 2 (BDCA2) and is being investigated for the potential treatment of systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE). Currently it is being evaluated in Phase II clinical trial in Participants with Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) with or without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy.

  • SAR443122: Sanofi

SAR443122 is a peripherally-restricted small molecule inhibitor of RIPK1 being evaluated in patients with cutaneous lupus erythematosus (CLE). Denali and Sanofi entered into a broad collaboration in October 2018 for the global development and commercialization of RIPK1 inhibitors. This includes peripherally restricted molecules such as SAR443122 (DNL758) and CNS-penetrant molecules such as DNL788 (SAR443820). A Phase II clinical study is assessing the efficacy and safety of the RIPK1-inhibitor SAR443122 in patients with moderate to severe subacute or discoid/chronic cutaneous lupus erythematosus.

The Cutaneous Lupus Erythematosus Pipeline Report Provides Insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Cutaneous Lupus Erythematosus with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Cutaneous Lupus Erythematosus Treatment.
  • Cutaneous Lupus Erythematosus Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Cutaneous Lupus Erythematosus Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Cutaneous Lupus Erythematosus market

Stay informed about the Cutaneous Lupus Erythematosus pipeline trends! Uncover critical updates on therapeutic innovations and their potential impact on patients and the healthcare industry @ Cutaneous Lupus Erythematosus Unmet Needs

Cutaneous Lupus Erythematosus Companies

Hoth Therapeutics, Zylo Therapeutics, Sanofi, Gilead Sciences, Bristol-Myers Squibb, Merck KGaA, Kyowa Kirin Co., Ltd., Priothera Ltd., Centessa Pharmaceuticals, and Horizon Therapeutics and others.

Cutaneous Lupus Erythematosus pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Infusion
  • Intradermal
  • Intramuscular
  • Intranasal
  • Intravenous
  • Oral
  • Parenteral
  • Subcutaneous
  • Topical.

Cutaneous Lupus Erythematosus Products have been categorized under various Molecule types such as

  • Gene therapies
  • Small molecule
  • Vaccines
  • Polymers
  • Peptides
  • Monoclonal antibodies

Transform your understanding of the Cutaneous Lupus Erythematosus Pipeline! See the latest progress in drug development and clinical research @ Cutaneous Lupus Erythematosus Market Drivers and Barriers, and Future Perspectives

Scope of the Cutaneous Lupus Erythematosus Pipeline Report

  • Coverage- Global
  • Cutaneous Lupus Erythematosus Companies- Hoth Therapeutics, Zylo Therapeutics, Sanofi, Gilead Sciences, Bristol-Myers Squibb, Merck KGaA, Kyowa Kirin Co., Ltd., Priothera Ltd., Centessa Pharmaceuticals, and Horizon Therapeutics and others.
  • Cutaneous Lupus Erythematosus Pipeline Therapies- Litifilimab, Daxdilimab, SOTYKTU (deucravacitinib), Edecesertib, DS-7011a, Enpatoran, and others.
  • Cutaneous Lupus Erythematosus Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Cutaneous Lupus Erythematosus Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Stay Ahead in Dermatology Research–Access the Full Cutaneous Lupus Erythematosus Pipeline Analysis Today! @ Cutaneous Lupus Erythematosus Drugs and Companies

Table of Content

  1. Introduction
  2. Executive Summary
  3. Cutaneous Lupus Erythematosus: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Cutaneous Lupus Erythematosus – DelveInsight’s Analytical Perspective
  7. In-depth Commercial Assessment
  8. Cutaneous Lupus Erythematosus Collaboration Deals
  9. Late Stage Products (Phase III)
  10. Drug Name: Company Name
  11. Mid Stage Products (Phase II)
  12. SAR443122: Sanofi
  13. Drug profiles in the detailed report…..
  14. Early Stage Products (Phase I)
  15. VIB7734: Horizon Therapeutics
  16. Drug profiles in the detailed report…..
  17. Pre-clinical and Discovery Stage Products
  18. HT-005 Z-Pods: Hoth Therapeutics/Zylo Therapeutics
  19. Inactive Products
  20. Cutaneous Lupus Erythematosus Key Companies
  21. Cutaneous Lupus Erythematosus Key Products
  22. Cutaneous Lupus Erythematosus- Unmet Needs
  23. Cutaneous Lupus Erythematosus- Market Drivers and Barriers
  24. Cutaneous Lupus Erythematosus- Future Perspectives and Conclusion
  25. Cutaneous Lupus Erythematosus Analyst Views
  26. Cutaneous Lupus Erythematosus Key Companies
  27. Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/cutaneous-lupus-erythematosus-pipeline-insight

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Cutaneous Lupus Erythematosus Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies

Public Launch (and Public Stage) of DC Think Tank of Ethical Physicians, Scientists, Academics – May 09-10, 2025 – in Front of White House

Healing Science Policy Institute (org deriving from 6000+ physicians, scientists, academics, practitioners rebuttal letter in support of Kennedy) launches on a public stage in front of the White House in historical moment to reshape scientific-medical narrative, ready to assist and lead in HHS restructuring.

DC-based policy think tank organizes to assist with HHS restructuring efforts from the largest public list of reputable Kennedy-supportive physicians, scientists, and academics who are grassroot leaders standing up, coming together, and flying in from all over the country.

We are seeking to engage the public, modeling transparency and openness, presenting problems and solutions to our currently broken systems of caring, evidence on novel or controversial topics that are not mainstream, and ultimately help America heal!

Presentations will be TED-style talks with fully open media questions after each talk. Speakers and topics include Gennaro Durso, PhD (open scientific debates), Vatsal Thakkar, MD (lack of open medical debates), James Thomas, MD (parasites), Brian Peskin, PhD (inflammation and seed oils), Robert Rowens, MD and Howard Robins, DPM (ozone & medical uses), Christopher Cassells, MD (fixing CMS), Johnathan Edwards, MD (pain, needles, taboos, trust), Craig M. Wax, DO (patient self-ownership), clinician Laurie A. Couture, MEd, LCMHC (psychiatric drug failures and harms), and many others, alongside citizen voices and stories in support of the restructuring/redesign of healthcare.

Media Contact
Company Name: Healing Science Policy Institute
Contact Person: Diana Lutfi
Email: Send Email
Phone: 6262003549
Address:Lafayette Park
City: Washington D.C.
Country: United States
Website: healscience.org

Car Haggle Helper Launches No-Risk Service That Saves New Car Buyers $4 – $8K on Average

USA – May 5, 2025 – Car Haggle Helper, a new U.S.-based car negotiation concierge, has officially launched to help consumers save thousands on their next vehicle – without stepping foot in a dealership. Designed as a no-risk, buyer-first service, Car Haggle Helper negotiates directly with multiple dealerships on behalf of the customer, saving buyers both time and money.

“We built Car Haggle Helper so the average car buyer could negotiate like a pro – without wasting hours or getting played by high-pressure sales tactics,” said John Petry, founder and CEO. “We save our clients $4,000 to $8,000 on average by bringing leverage, data, and strategy into a process that’s typically stacked against them.”

One recent client, Erica Cracco, a busy mom of two from Connecticut shared: “Car Haggle Helper saved me $9,400 on my new Volvo—and handled everything from start to finish. I didn’t have time to play dealership games. This was a total lifesaver.”

With car prices still near record highs, many consumers are overpaying or falling victim to confusing dealership tactics. Car Haggle Helper flips the script by acting solely on behalf of the buyer – not the dealer. And with a no-savings, no-fee guarantee, it’s the only risk-free car buying service on the market today.

Solving a Common Problem With a Smarter Playbook

The average car buyer spends over 15 hours researching, shopping and buying their vehicle – yet still walks away with regrets. Nearly 40% of buyers say they wish they’d gotten a better deal. For busy families and working professionals, that’s time they simply can’t afford to lose.

Car Haggle Helper changes that by stepping in as a professional advocate, offering insider strategies, multi-dealer bidding power, and a buyer-first mindset – all handled remotely.

The service focuses on out-the-door pricing – not just monthly payments that hide inflated fees – and uses competitive pressure between dealerships to drive down the final cost.

How It Works

Buyers start by submitting a short form with the make, model, features, and location of the car they want. Car Haggle Helper then contacts multiple dealerships, initiates real-time bidding, uncovers hidden fees and incentives, and negotiates the out-the-door price – not just monthly payments that hide inflated costs.

If Car Haggle Helper doesn’t save the buyer money, the service is 100% free.

Built to Protect the Buyer

Car Haggle Helper works exclusively for the buyer – never the dealership. The company has no dealer affiliations, no commissions, and no hidden markups. That means every negotiation is fully transparent, and every quote is designed to save the buyer as much as possible.

The service is especially valuable for first-time buyers, busy families, professionals, and anyone unfamiliar with how to spot dealer tricks. It replaces hours of negotiation and showroom pressure with a streamlined process that delivers real savings – without the time sink.

Consumers ready to save thousands on their next car can visit CarHaggleHelper.com.

About Car Haggle Helper

Car Haggle Helper is a U.S.-based negotiation concierge that helps car buyers save $4,000 to $8,000 on average through expert, multi-dealer bidding. With a no-savings, no-fee guarantee, the company delivers transparent, buyer-first support and handles everything from dealer outreach to final pricing. Learn more at CarHaggleHelper.com.

Media Contact
Company Name: Car Haggle Helper
Email: Send Email
Country: United States
Website: https://carhagglehelper.com/

The Boulder Group Arranges Sale of Single Tenant Advance Auto Parts in the Atlanta MSA

The Boulder Group’s Brandon Wright and Zach Wright represented the seller in the transaction.

The Boulder Group has completed the sale of a single tenant Advance Auto Parts located at 164 Temple Ave in Newnan, GA for $1,570,000. The Boulder Group’s Brandon Wright and Zach Wright represented the seller in the transaction. The seller was a private Colorado-based investor and the purchaser was a Georgia-based family office in a 1031 exchange. The all-cash transaction quickly closed in only 24 days.

The Advance Auto Parts property is located at the hard corner of a signalized intersection. The property is in an affluent area with average annual household income of $97,000 within a mile. The Advance Auto Parts property out-positions nearby competitors AutoZone and O’Reilly Auto Parts. Newnan is located within the Atlanta MSA and approximately 35 miles southwest of Downtown Atlanta.

Advance Auto Parts has a long operating history at this location and recently extended their lease early demonstrating commitment to this location. Advance Auto Parts is a publicly traded company (NYSE: AAP) with a $2B market capitalization.

“The average age of a vehicle in the U.S. is currently a record-high 12.6 years old. The aging fleet of vehicles will continue to create strong demand for auto parts moving forward. As a result, many net lease investors continue to be bullish on the auto parts space and are acquiring well-located auto parts properties,” stated Zach Wright, Vice President.

“Net lease properties with low overall rents and price points that are located in business-friendly states and growth markets are at the forefront of investor demand,” said Brandon Wright, Associate.

About The Boulder Group

The Boulder Group is a boutique investment real estate service firm specializing in single tenant net lease properties. The firm provides a full range of brokerage, advisory, and financing services nationwide to a substantial and diversified client base, which includes high-net-worth individuals, developers, REITs, partnerships and institutional investment funds. Founded in 1997, the firm has arranged the acquisition and disposition of over $9 billion of single tenant net lease real estate transactions. From 2013-2024, the firm was ranked in the top 10 companies in the nation for single tenant retail transactions by both Real Capital Analytics and CoStar. The Boulder Group is headquartered in suburban Chicago and has an office in Denver.

For additional information, please visit www.BoulderGroup.com

Media Contact
Company Name: The Boulder Group
Contact Person: Zach Wright
Email: Send Email
Phone: 720-604-2220
Address:1805 S Bellaire Street, Suite 355
City: Denver
State: Colorado
Country: United States
Website: https://www.bouldergroup.com/NNN-Properties-For-Sale.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Boulder Group Arranges Sale of Single Tenant Advance Auto Parts in the Atlanta MSA

Lucintel Forecasts the Global Cancer Testing Screening Market to Reach $161 billion by 2031

“According to a market report by Lucintel, the future of the global cancer testing screening market looks promising with opportunities in the hospital, clinic, diagnostic center, and research institute applications. The global cancer testing screening market is expected to reach an estimated $161 billion by 2031 from $91.7 billion in 2024, at a CAGR of 7.9% from 2025 to 2031.”
According to a market report by Lucintel, the future of the global cancer testing screening market looks promising with opportunities in the hospital, clinic, diagnostic center, and research institute applications. The global cancer testing screening market is expected to reach an estimated $161 billion by 2031 from $91.7 billion in 2024, at a CAGR of 7.9% from 2025 to 2031.

According to a market report by Lucintel, the future of the global cancer testing screening market looks promising with opportunities in the hospital, clinic, diagnostic center, and research institute applications. The global cancer testing screening market is expected to reach an estimated $161 billion by 2031 from $91.7 billion in 2024, at a CAGR of 7.9% from 2025 to 2031. The major drivers for this market are rising prevalence of cancer cases, growing need for accurate diagnostic tools and early detection methods, and increasing preference for liquid biopsy.

A more than 150-page report to understand trends, opportunity and forecast in cancer testing screening market to 2031 by technique (imaging, biopsy, genomic and molecular tests, next generation sequencing, RT-PCR, microarrays, biomarker testing, and others), cancer type (respiratory system cancer, leukemia, myeloma and lymphoma, skin cancer, abdominal/digestive system cancer, urinary system cancer, endocrine system cancer, breast cancer, and others), application (hospitals, clinics, diagnostic centers, research institutes, and others), end use (patients, healthcare providers, diagnostic laboratories, research institutes, and pharmaceutical companies), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that biopsy is expected to witness highest growth over the forecast period due to its great accuracy in the diagnosis of cancer.

Hospital is expected to witness highest growth over the forecast perioddue to rising patients preference for this facility for their treatment given to the availability of well established infrastructure and presence of medical expertise.

Download sample by clicking on cancer testing screening market

North America is expected to witness highest growth over the forecast period due to constant increase in instances of prostate and lung cancer cases in the region.

Diasorin, Immunodiagnostic Systems, Epigenomics, Quest Diagnostics, F. Hoffmann-La Roche, VolitionRX, Abbott Laboratories, QIAGEN, Siemens Healthineers are the major suppliers in the cancer testing screening market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel’s Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1-972-636-5056

Explore Our Latest Publications

Dental Implant and Prosthetic Market

Eyewear Market

Stationary Gas Analyzer Market

Spherical Superalloy Powder Market

Volumetric Display Market

Patch Cable Market

Flexible Pipe Market

Flooring Market

Food Safety Testing Market

Electric Bus Market

 

Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email: Send Email
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Lucintel Forecasts the Global Cancer Testing Screening Market to Reach $161 billion by 2031

Preferred Garage Doors Northglenn Enhances Local Services with Expert Solutions

Preferred Garage Doors Northglenn Enhances Local Services with Expert Solutions

Northglenn, CO – Preferred Garage Doors Northglenn continues to provide top-tier solutions for residential and commercial properties, ensuring seamless operation and long-lasting performance. Specializing in Garage Door Repair Northglenn, the company delivers prompt and efficient service to address any mechanical or operational issues.

As a trusted provider, Preferred Garage Doors Northglenn offers a wide selection of Garage Doors Northglenn, catering to various styles and functional needs. Whether modern or traditional, each installation is performed with precision and attention to detail. Expert technicians ensure every door enhances curb appeal while providing durability and security.

In addition to repair and replacement services, professional Garage Door Installation Northglenn is available, ensuring reliable and secure setups for residential and commercial applications. Each installation follows industry standards, utilizing high-quality materials and advanced technology to maximize performance.

With a reputation built on reliability and expertise, Preferred Garage Doors Northglenn remains committed to excellence. Customers can expect timely service, skilled craftsmanship, and lasting results. For more information, visit the company website or contact a representative to schedule a consultation.

Media Contact
Company Name: Preferred Garage Doors Northglenn
Contact Person: William Tyndall
Email: Send Email
Phone: (720) 881-0912
Address:10650 Irma Dr unit 12
City: Northglenn
State: CO 80233
Country: United States
Website: https://preferredgaragedoorsdenver.com/northglenn/

Elite Roofing & Gutters Announces Launch of New Commercial Division

Elite Expanding Superior Craftsmanship into Commercial Roofing Solutions

Elite Roofing & Gutters, formerly known as Complete Exteriors, proudly announces the launch of its new commercial division, marking a major milestone in the company’s evolution from trusted residential roofing experts to a full-service leader in commercial roofing. Since its founding in 2007, Elite Roofing & Gutters has built a reputation for exceeding client expectations through exceptional craftsmanship and superior service. This latest expansion reflects their unwavering commitment to meeting the roofing needs of businesses throughout Mississippi, Louisiana, and Alabama.

“We’ve been privileged to work on several significant commercial projects over the years, including churches, office buildings, and city halls,” says Joe Boyd, Founder and CEO of Elite Roofing & Gutters. “The launch of our commercial division allows us to formally expand our focus and provide businesses with comprehensive roofing solutions tailored specifically to their needs.”

Comprehensive Commercial Roofing Services

The new commercial division offers a full suite of services, including installation, repair, and maintenance for a wide variety of roofing systems. These include:

  • Standing Seam Metal Roofing: Durable, energy-efficient, and designed for long-term performance.

  • Roof Coatings: Restorative and protective coatings to extend roof lifespan.

  • Single-Ply Membranes (TPO, EPDM, PVC): Lightweight, energy-efficient membranes ideal for insulation and versatile commercial applications.

  • Roof Maintenance & Repairs: Services designed to maximize the longevity of your commercial roof.

  • Large Area Shingle Replacements: Perfect for churches, medical facilities, retail centers, and more.

With decades of combined experience, Elite Roofing & Gutters provides thoughtful, high-quality solutions to protect businesses and their operations.

Strategic Team Appointments

To ensure the success and growth of the new division, Elite Roofing & Gutters has appointed Greg Owen as division lead. With a robust background in commercial roofing and project management, Greg brings expertise and leadership to this exciting expansion.

Additionally, Elite has welcomed Lauren Swain to its team of industry professionals. Swain’s roofing career began at her family business, No Drip Roofing, where she gained hands-on experience working alongside her father and brother. Specializing in roofing and coatings, she has worked on everything from churches to medical facilities, earning her reputation as a trusted expert in the field.

About Elite Roofing & Gutters

Elite Roofing & Gutters, headquartered in Pearl, Mississippi, and with additional locations in Hattiesburg, Gulfport, and Oxford, has been providing top-quality roofing services since 2007. With a steadfast dedication to craftsmanship, innovation, and unparalleled customer service, the company has consistently set the standard for roofing excellence across the region. Under the leadership of Joe Boyd, Elite rebranded in 2025 to better reflect its comprehensive offerings, which include residential, specialty, and now commercial roofing solutions.

Video Link: https://www.youtube.com/embed/prJp_yCT2p8

Media Contact
Company Name: Elite Roofing and Gutters
Contact Person: Adam Horlock
Email: Send Email
Phone: (601) 326-2755
Address:25 Highway 80 E
City: Pearl
State: Mississippi
Country: United States
Website: https://eliteroofer.com/

Preferred Garage Doors Provides Reliable Garage Door Solutions in Thornton

Preferred Garage Doors Provides Reliable Garage Door Solutions in Thornton

May 5, 2025 – Thornton, CO – A well-functioning garage door is essential for security, convenience, and the overall functionality of any home or business. Preferred Garage Doors continues to offer professional repair, maintenance, and installation services to ensure smooth operation and long-term durability. With a strong reputation for reliability and expertise, the company remains a trusted provider for residents and business owners in Thornton.

Comprehensive Garage Door Services for Thornton Homes and Businesses

Garage doors endure constant use and exposure to weather conditions, which can lead to wear and tear over time. From minor issues to major repairs, Preferred Garage Doors provides a full range of services to keep garage doors operating safely and efficiently. Highly trained technicians assess each situation carefully, offering tailored solutions that extend the life of garage door systems.

Expert Garage Door Repairs in Thornton

Mechanical failures, misaligned tracks, and worn-out components can cause garage doors to malfunction. Timely repairs are essential to prevent further damage and avoid costly replacements. Preferred Garage Doors specializes in Garage Door Repair Thornton, quickly diagnosing and resolving issues to restore smooth operation. Whether dealing with a noisy door, damaged panels, or a faulty opener, professional technicians provide effective solutions with lasting results.

Professional Garage Door Spring Replacement

Garage door springs are under constant tension and play a crucial role in the lifting mechanism. Over time, these springs can weaken or break, leading to operational failure and potential safety hazards. Preferred Garage Doors offers Garage Door Spring Replacement Thornton to ensure safe and efficient functionality. Technicians use high-quality, durable springs to provide precision replacements that restore balance and improve overall door performance.

Routine Maintenance and Garage Door Services

Preventative maintenance helps avoid unexpected breakdowns and costly repairs. Preferred Garage Doors provides regular Garage Door Service Thornton to ensure all components function optimally. Inspections, lubrication, and adjustments help identify potential issues before they become major problems, extending the life of garage doors and reducing long-term maintenance costs.

Emergency Garage Door Repairs for Immediate Assistance

A malfunctioning garage door can be more than an inconvenience—it can pose security risks and safety hazards. Preferred Garage Doors offers emergency repair services to address urgent situations quickly and efficiently. Whether a garage door is stuck in the open position or refuses to close properly, experienced technicians provide prompt assistance to restore security and functionality.

High-Quality Parts and Professional Installation

Quality materials and expert craftsmanship are key to long-lasting garage door performance. Preferred Garage Doors uses premium components for all repairs and installations, ensuring durability and reliability. Whether replacing worn-out parts or installing a new door system, the company prioritizes precision and attention to detail.

About Preferred Garage Doors

Preferred Garage Doors is a trusted garage door service provider in Thornton, CO, specializing in repair, maintenance, and installation. With a team of skilled technicians and a commitment to quality, the company delivers reliable solutions for residential and commercial garage doors.

Media Contact
Company Name: Preferred Garage Doors – Thornton
Contact Person: William Tyndall
Email: Send Email
Phone: (720) 802-5994
Address:4841 E 144th Dr
City: Thornton
State: CO 80602
Country: United States
Website: https://preferredgaragedoorsdenver.com/

Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031

“According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031.”
According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031.

According to a market report by Lucintel, the future of the global MRD testing market looks promising with opportunities in the hospitals and specialty clinic, diagnostic laboratory, and academic & research institutes markets. The global MRD testing market is expected to reach an estimated $3.4 billion by 2031 from $1.6 billion in 2024, at a CAGR of 11.7% from 2025 to 2031. The major drivers for this market are increasing occurrence of blood-related cancers, growing global elderly population, and progress in technology for minimal residual disease (MRD) testing.

A more than 150-page report to understand trends, opportunity and forecast in MRD testing market to 2031 by technology (flow cytometry, polymerase chain reaction (PCR), next-generation sequencing (NGS), and others), application (hematological malignancies, leukemia, lymphoma, solid tumors, and others), end use industry (hospitals and specialty clinics, diagnostic laboratories, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that Polymerase Chain Reaction (PCR) is expected to witness highest growth over the forecast period.

Within this market, hospitals and specialty clinics will remain the largest segment.

Download sample by clicking on MRD testing market

APAC is expected to witness highest growth over the forecast period.

Labcorp, F. Hoffmann-La Roche, Guardant Health, Sysmex Corporation, Neogenomics Laboratories, Adaptive Biotechnologies Corporation, Archerdx, Asuragen, Arup Laboratories are the major suppliers in the MRD testing market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel’s Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1-972-636-5056

Explore Our Latest Publications

Hi-Fi System Market

Bearing for Mechanical and Electrical Product

Telecom Electronic Manufacturing Service Market

Timing Device Market

Visual Inspection Microscope Market

Construction Waste Crusher Market

Nonwovens for Construction Market

OSB Panel for Construction Market

Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email: Send Email
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Lucintel Forecasts the Global MRD Testing Market to Reach $3.4 billion by 2031

Lucintel Forecasts the Global Patient-Centric Health Care App Market is expected to grow with a CAGR of 17.6% from 2025 to 2031

“According to a market report by Lucintel, the future of the global patient-centric health care app market looks promising with opportunities in the hospital, clinic and home use markets. The global patient-centric health care app market is expected to grow with a CAGR of 17.6% from 2025 to 2031”
According to a market report by Lucintel, the future of the global patient-centric health care app market looks promising with opportunities in the hospital, clinic and home use markets. The global patient-centric health care app market is expected to grow with a CAGR of 17.6% from 2025 to 2031

According to a market report by Lucintel, the future of the global patient-centric health care app market looks promising with opportunities in the hospital, clinic and home use markets. The global patient-centric health care app market is expected to grow with a CAGR of 17.6% from 2025 to 2031. The major drivers for this market are rising healthcare expenses, growing emphasis on preventative care, expanding health and wellness trends, expediting telemedicine adoption, increased patient demands for convenience, and supportive government efforts.

A more than 150-page report to understand trends, opportunity and forecast in patient-centric health care app market to 2031 by technology (phone-based apps, web-based apps, and wearable patient centric apps), operating system (iOS, android, windows, and others), application (wellness management and disease and treatment management), end use (hospitals, clinics, and home use), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that phone-based app is expected to witness the highest growth over the forecast period due to ubiquitous presence of smartphones.

Within this market, hospital will remain the largest segment due to growing focus on patient-centric care and healthcare models centered around value.

Download sample by clicking on patient-centric health care app market

North America will remain the largest region over the forecast period due to advancement in technology, along with the rising presence of numerous healthcare technology companies and startups.

Bayer Aktiengesellschaft, Boston Scientific Corporation, Hill-Rom Services, iPatientCare, Koninklijke Philips, Merck & Co, Pfizer, Google, Apple, Siemens Healthineers are the major suppliers in the patient-centric health care app market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com To get access of more than 1000 reports at fraction of cost visit Lucintel’s Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1-972-636-5056

Explore Our Latest Publications

Imaging Chemical Market

Leather Chemical Market

Microelectronic Medical Implants Market

Satellite Communication Market

Space Sensors and Actuators Market

Video Analytics Market

Vertical Lift Module Market

Vein Illuminator Market

Stereolithography 3D Printing Technology Market

Industrial Gas for the Flat Panel Display Market

Media Contact
Company Name: Lucintel
Contact Person: Roy Almaguer
Email: Send Email
Phone: 972.636.5056
Address:8951 Cypress Waters Blvd., Suite 160
City: Dallas
State: TEXAS
Country: United States
Website: https://www.lucintel.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Lucintel Forecasts the Global Patient-Centric Health Care App Market is expected to grow with a CAGR of 17.6% from 2025 to 2031